Cargando…

Risk factors of venous thromboembolism in anti-PLA2R-positive and negative primary membranous nephropathy

Detalles Bibliográficos
Autores principales:	Wu, Henry H L, Alozai, Abdur, Li, Jennifer W C, Elmowafy, Ahmed, Ponnusamy, Arvind, Woywodt, Alexander, Jeyalan, Vishnu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308090/ https://www.ncbi.nlm.nih.gov/pubmed/35892019 http://dx.doi.org/10.1093/ckj/sfac052

Ejemplares similares

Horseshoe kidney with PLA2R-positive membranous nephropathy
por: Shi, Shuai-Shuai, et al.
Publicado: (2021)

Malignancy-Associated Membranous Nephropathy with Positive Anti-PLA2R Autoantibodies: Coincidence or Connection
por: Baker, Lyle W., et al.
Publicado: (2021)

Bortezomib Treatment for Refractory PLA2R-Positive Membranous Nephropathy
por: Geara, Abdallah S., et al.
Publicado: (2021)

Statins can benefit patients with primary membranous nephropathy on venous thromboembolism
por: Zou, Peimei, et al.
Publicado: (2021)

Anti-PLA(2)R Antibodies in Chinese Patients with Membranous Nephropathy
por: Li, Xin, et al.
Publicado: (2016)

Native and transplant kidney histopathological manifestations in association with COVID-19 infection: A systematic review
por: Jeyalan, Vishnu, et al.
Publicado: (2021)

Favorable outcome in PLA2R positive HBV-associated membranous nephropathy
por: Chen, Ruiying, et al.
Publicado: (2022)

Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous Nephropathy
por: Logt, Anne-Els van de, et al.
Publicado: (2021)

The application of podocyte antigen PLA2R and anti-PLA2R antibody in the diagnosis and treatment of membranous nephropathy
por: Chen, Yang, et al.
Publicado: (2023)

Successful treatment of PLA(2)R1-antibody positive membranous nephropathy with ocrelizumab
por: Schmidt, Tilman, et al.
Publicado: (2020)

Serum Levels of BAFF and APRIL Predict Clinical Response in Anti-PLA2R-Positive Primary Membranous Nephropathy
por: Netti, Giuseppe Stefano, et al.
Publicado: (2019)

Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach
por: Wang, Song, et al.
Publicado: (2023)

The Prognostic Value of Anti-PLA2R Antibodies Levels in Primary Membranous Nephropathy
por: Kukuy, Olga Lesya, et al.
Publicado: (2023)

Kikuchi disease preceding systemic lupus erythematosus with membranous lupus nephritis
por: Ponnusamy, Arvind, et al.
Publicado: (2009)

Can use of the serum anti-PLA(2)R antibody negate the need for a renal biopsy in primary membranous nephropathy?
por: Ragy, Omar, et al.
Publicado: (2023)

Landmark Papers in Nephrology
por: Ponnusamy, Arvind, et al.
Publicado: (2013)

Bilateral Renal Vein Thrombosis in Membranous Nephropathy: Hypoalbuminemia Predictive of Venous Thromboembolism in Nephrotic Syndrome
por: Casey, Derek, et al.
Publicado: (2022)

Urine anti-PLA2R antibody is a novel biomarker of idiopathic membranous nephropathy
por: Wang, Yu, et al.
Publicado: (2017)

Membranous nephropathy PLA2R+ associated with Chagas disease
por: Xavier-Júnior, José Cândido Caldeira, et al.
Publicado: (2015)

The Role of PLA2R Antibody in Treatment of Membranous Nephropathy
por: Dahan, Karine, et al.
Publicado: (2017)

PLA2R antibodies and PLA2R glomerular deposits in psoriasis patients with membranous nephropathy
por: Ge, Yong-Chun, et al.
Publicado: (2016)

Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy
por: Hihara, Kei, et al.
Publicado: (2016)

Efficacy and Safety of Rituximab in Hepatitis B Virus–Associated PLA2R-Positive Membranous Nephropathy
por: Berchtold, Lena, et al.
Publicado: (2017)

A rare case of PLA2R- and THSD7A-positive idiopathic membranous nephropathy
por: Wanderley, David Campos, et al.
Publicado: (2019)

Rare Occurrence of PLA2R-Positive Membranous Nephropathy in a Patient with Sjogren's Syndrome and CIDP
por: Gupta, Nimish, et al.
Publicado: (2020)

A Case of Pla2r and Exostosin 1 Positive Membranous Nephropathy - The Diagnostic and Therapeutic Dilemma
por: Sivagnanam, Harish, et al.
Publicado: (2023)

Monitoring anti-PLA2R antibody titres to predict the likelihood of spontaneous remission of membranous nephropathy
por: Jatem-Escalante, Elias, et al.
Publicado: (2021)

Serum anti-PLA2R antibody and glomerular PLA2R deposition in Chinese patients with membranous nephropathy: A cross-sectional study
por: Pang, Lu, et al.
Publicado: (2017)

Analysis of glomerular PLA2R efficacy in evaluating the prognosis of idiopathic membranous nephropathy in the background of different serum anti-PLA2R levels
por: Sun, Yuemeng, et al.
Publicado: (2022)

The value of PLA2R antigen and IgG subclass staining relative to anti-PLA2R seropositivity in the differential diagnosis of membranous nephropathy
por: Bajcsi, Dóra, et al.
Publicado: (2023)

Concurrent PLA2R-Associated Membranous Nephropathy and Antiglomerular Basement Membrane Disease
por: Jagannathan, Geetha, et al.
Publicado: (2022)

Single-Cell Profiling Reveals Transcriptional Signatures and Cell-Cell Crosstalk in Anti-PLA2R Positive Idiopathic Membranous Nephropathy Patients
por: Xu, Jie, et al.
Publicado: (2021)

The investigative burden of membranous nephropathy in the UK
por: Hamilton, Patrick, et al.
Publicado: (2019)

PLA2R-Negative Membranous Nephropathy Presenting as a Prodrome of IgG4-Related Autoimmune Pancreatitis
por: Velegraki, Magdalini, et al.
Publicado: (2019)

The characters of antibodies against PLA2R in healthy individuals and in the patient with PLA2R associated membranous nephropathy
por: Cheng, Yan-jiao, et al.
Publicado: (2023)

Diagnostic Test Accuracy of Serum Anti-PLA2R Autoantibodies and Glomerular PLA2R Antigen for Diagnosing Idiopathic Membranous Nephropathy: An Updated Meta-Analysis
por: Li, Weiying, et al.
Publicado: (2018)

Correction: The characters of antibodies against PLA2R in healthy individuals and in the patient with PLA2R associated membranous nephropathy
por: Cheng, Yan-jiao, et al.
Publicado: (2023)

Clinical value of a serum anti-PLA2R antibody in the diagnosis and monitoring of primary membranous nephropathy in adults
por: Wu, Xueping, et al.
Publicado: (2018)

Anti-PLA2R antibody measured by ELISA predicts the risk of vein thrombosis in patients with primary membranous nephropathy
por: Zhu, Huizi, et al.
Publicado: (2022)

Etanercept-Induced Anti-Glomerular Basement Membrane Disease
por: Al-Chalabi, Saif, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ifid4460d9gtai3u6jfanfq8vo